Position
Chief Executive Officer
Company
Franklin Biolabs
Description
Franklin Biolabs has named Vatsala Naageshwaran, PhD, an award-winning biopharmaceutical executive, as the Chief Executive Officer. Dr. Naageshwaran brings deep experience driving scientific results and business growth, with a commitment to progressing advanced therapies for patients.
Other recent leadership changes in Genetics and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Lexeo Therapeutics Appoints Dr. Kyle Rasbach as Chief Financial Officer (December 19, 2024)
- HuidaGene Therapeutics Appoints TJ Cradick, PhD as Chief Technology Officer (October 21, 2024)
- ITF Therapeutics Appoints Erica L. Monaco as Chief Operating Officer (December 4, 2024)
- Incendia Therapeutics Appoints Bradford Smith as Chief Financial Officer (December 3, 2024)
- Nouscom Appoints Eckhard Niemeier as Chief Business Officer (December 3, 2024)
- Beam Therapeutics Inc. Appoints Sravan K. Emany as Chief Financial Officer (December 6, 2024)
Who to call at Franklin Biolabs, and when
A new leader at Franklin Biolabs brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Franklin Biolabs raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Franklin Biolabs, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Franklin Biolabs. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Franklin Biolabs changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Franklin Biolabs changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.